β4 integrin amplifies erbB2 signaling to promote mammary tumorigenesis Journal Article


Authors: Guo, W.; Pylayeva, Y.; Pepe, A.; Yoshioka, T.; Muller, W. J.; Inghirami, G.; Giancotti, F. G.
Article Title: β4 integrin amplifies erbB2 signaling to promote mammary tumorigenesis
Abstract: Amplification of the ErbB2 locus, which encodes a receptor tyrosine kinase, is common in aggressive breast tumors and correlates with poor prognosis. The mechanisms underlying ErbB2-mediated breast carcinoma progression remain incompletely defined. To examine the role of the signaling and cell-adhesion receptor β4 integrin during ErbB2-mediated tumorigenesis, we introduced a targeted deletion of the β4 signaling domain into a mouse model of ErbB2-induced mammary carcinoma. Loss of β4 signaling suppresses mammary tumor onset and invasive growth. Ex vivo studies indicate that β4 forms a complex with ErbB2 and enhances activation of the transcription factors STAT3 and c-Jun. STAT3 contributes to disruption of epithelial adhesion and polarity, while c-Jun is required for hyperproliferation. Finally, deletion of the β4 signaling domain enhances the efficacy of ErbB2-targeted therapy. These results indicate that β4 integrin promotes tumor progression by amplifying ErbB2 signaling and identify β4 as a potential target for molecular therapy of breast cancer. © 2006 Elsevier Inc. All rights reserved.
Keywords: signal transduction; controlled study; gene deletion; mutation; cancer growth; drug efficacy; nonhuman; drug targeting; protein domain; protein function; cell proliferation; animal cell; mouse; animals; mice; animal tissue; cells, cultured; stat3 protein; transcription initiation; epidermal growth factor receptor 2; animal experiment; animal model; cancer model; mice, transgenic; cell transformation, neoplastic; cancer invasion; breast carcinoma; carcinoma; stat3 transcription factor; cell polarity; protein structure, tertiary; receptor, erbb-2; epithelium; up-regulation; disease models, animal; ex vivo study; cell adhesion; breast carcinogenesis; macromolecular substances; mammary neoplasms, experimental; beta4 integrin; integrin beta4; jnk mitogen-activated protein kinases; protein c jun
Journal Title: Cell
Volume: 126
Issue: 3
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2006-08-11
Start Page: 489
End Page: 502
Language: English
DOI: 10.1016/j.cell.2006.05.047
PUBMED: 16901783
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 162" - "Export Date: 4 June 2012" - "CODEN: CELLB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wenjun Guo
    9 Guo